CROI 2015 Program and Abstracts

Abstract Listing

Poster Abstracts

Conclusions: With this low level of engagement in harm reduction strategies among Nigerian MSM, interventions that promote communication between sex partners to adopt harm reduction and engage the full spectrum of combination prevention strategies promoted by the TRUST intervention are a focus of ongoing study, including how to influence normative behaviors in sexual networks.

TUESDAY, FEBRUARY 24, 2015 Session P-X1 Poster Session

Poster Hall

2:30 pm– 4:00 pm Paying for Care 1064 RyanWhite HIV/AIDS Program Assistance and HIV Treatment Outcomes in the United States Heather Bradley 1 ; Abigail H.Viall 1 ; Pascale M.Wortley 1 ; Antigone Dempsey 2 ; Heather Hauck 2 ; Jacek Skarbinski 1 1 US Centers for Disease Control and Prevention (CDC), Atlanta, GA, US; 2 US Health Resources and Services Administration, Rockville, MD, US Background: The Ryan White HIV/AIDS Program (RWHAP) is the payer of last resort for HIV medical care, medications, and supportive services for uninsured and underinsured persons living with HIV in the United States. Methods: We assessed the association between RWHAP assistance, alone or in combination with other sources of healthcare coverage, and antiretroviral treatment (ART) prescription and viral suppression ( ≤ 200 copies/ml). We used 2009–2010 data from the Medical Monitoring Project (MMP), a surveillance system that provides nationally representative data about HIV-infected adults receiving medical care. Data were collected on 8,691 patients through interviews and medical record abstractions. Data were weighted to account for unequal probabilities of selection and both facility and patient nonresponse. Results: Among adults with HIV infection and recieving medical care in the United States, 40.2% received any RWHAP assistance, and 14.7% relied solely on RWHAP assistance for HIV care (i.e., were otherwise uninsured). Nearly 57% of patients had other health care coverage only, including private insurance (17.0%), Medicaid (16.6%), Medicare (3.3%), or both (9.6%); 3.1%were uninsured with no RWHAP assistance. Overall, 89.6% of patients were prescribed ART, and 72.9%were virally suppressed. Compared to uninsured patients without RWHAP assistance, uninsured patients with RWHAP assistance were significantly more likely to be prescribed ART (43.6% versus 93.7%; P <0.01) and to be virally suppressed (36.1% versus 76.9%; P <0.01). After adjusting for patient characteristics, those with private insurance, Medicaid, or Medicare were 7%, 9%, and 5% less likely, respectively, to be prescribed ART than those with RWHAP only ( P <0.05). Patients with private insurance, Medicaid, and Medicare were 7%, 15%, and 10% less likely, respectively, to be virally suppressed ( P <0.05) than those with RWHAP only. Patients whose private insurance or Medicaid coverage was supplemented by RWHAP were more likely to be prescribed ART than those without RWHAP supplementation ( P <0.05) (figure 1). Similarly, those whose Medicaid or Medicare coverage was supplemented by RWHAP were more likely to be virally suppressed than those without RWHAP supplementation ( P <0.05).

Poster Abstracts

621

CROI 2015